Founded in 2009, JYMed is a leading peptide CRDMO service provider and generic API manufacturer in China specializing in the custom synthesis, process development, clinical supply and commercialization of peptide substances. The company employs approximately 600+ FTEs, with a core management team composed of experts with over 20 years of experience in peptide technology. JYMed operates one R&D center and two major multi-purpose production facilities, with multi-ton scale peptide manufacturing capacity.